Cochrane · systematic review · CD013083

Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism

Harvey, JJ, Huang, S, Uberoi, R · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library

VascularAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 4 · 57.1%Very low 3 · 42.9%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Ultrasound‐assisted catheter‐directed thrombolysis plus standard intravenous heparinisation versus standard intravenous heparinisation

Population: people with intermediate‐risk (submassive) APE
7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality(7‐day)
Ultrasound‐assisted catheter‐directed thrombolysis plus standard intravenous heparinisation vs standard intravenous heparinisation
no estimate extracted1 study · 59 participantsUngraded
All‐cause mortality (90‐day)
Ultrasound‐assisted catheter‐directed thrombolysis plus standard intravenous heparinisation vs standard intravenous heparinisation
OR 0.31 [0.01, 7.96]1 study · 59 participantsVery low
Downgraded: risk of bias, imprecision
Treatment‐associated major haemorrhage (
Ultrasound‐assisted catheter‐directed thrombolysis plus standard intravenous heparinisation vs standard intravenous heparinisation
no estimate extracted1 study · 59 participantsUngraded
Treatment‐associated minor haemorrhage (
Ultrasound‐assisted catheter‐directed thrombolysis plus standard intravenous heparinisation vs standard intravenous heparinisation
OR 3.11 [0.3, 31.79]1 study · 59 participantsVery low
Downgraded: risk of bias, imprecision
Recurrent APE requiring retreatment or change to a different APE treatment (
Ultrasound‐assisted catheter‐directed thrombolysis plus standard intravenous heparinisation vs standard intravenous heparinisation
no estimate extracted1 study · 59 participantsUngraded
Length of hospital stay (days)
Ultrasound‐assisted catheter‐directed thrombolysis plus standard intravenous heparinisation vs standard intravenous heparinisation
no estimate extracted1 study · 59 participantsVery low
Downgraded: risk of bias, imprecision
Quality of life Â
Ultrasound‐assisted catheter‐directed thrombolysis plus standard intravenous heparinisation vs standard intravenous heparinisation
no estimate extracted1 study · 59 participantsUngraded